RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [04/21/2025 10:29 PDT] RadNet, Inc. (NASDAQ:RDNT), Down By 100% ($53.36) From $53.36 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [04/21/2025 07:11 PDT] RDNT Expected to Trade Down Short Term
• [04/21/2025 07:09 PDT] RDNT Expected to Trade Down After Bearish Patterns Develop
• [04/15/2025 07:43 PDT] RDNT Expected to Trade Down After Bearish Patterns Develop
• [04/11/2025 07:27 PDT] RDNT Expected to Trade Up After Bullish Patterns Develop
• [04/07/2025 08:02 PDT] RDNT Expected to Trade Down After Bearish Patterns Develop